{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T06:46:11Z","timestamp":1765521971830,"version":"3.48.0"},"reference-count":109,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Vaccines"],"published-print":{"date-parts":[[2025,12,31]]},"DOI":"10.1080\/14760584.2025.2539884","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T08:05:16Z","timestamp":1753689916000},"page":"769-781","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Vaccination in adults at-increased risk of herpes zoster in Canada: insights from a multidisciplinary panel consensus"],"prefix":"10.1080","volume":"24","author":[{"given":"Wayne","family":"Ghesqui\u00e8re","sequence":"first","affiliation":[{"name":"University of British Columbia","place":["Victoria, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Tessier","sequence":"additional","affiliation":[{"name":"H\u00f4pital Saint-Luc du CHUM in the Groupe de m\u00e9decine de famille du Quartier Latin","place":["Montreal, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivien","family":"Brown","sequence":"additional","affiliation":[{"name":"University of Toronto","place":["Toronto, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lyn","family":"Guenther","sequence":"additional","affiliation":[{"name":"Guenther Research Inc","place":["London, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek","family":"Haaland","sequence":"additional","affiliation":[{"name":"McMaster University","place":["Hamilton, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Igoe","sequence":"additional","affiliation":[{"name":"Dalhousie University","place":["Halifax, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly S.","family":"MacDonald","sequence":"additional","affiliation":[{"name":"University of Manitoba","place":["Winnipeg, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn","family":"Whiskin","sequence":"additional","affiliation":[{"name":"The Charlton Centre for Specialized Treatment","place":["Hamilton, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,8,5]]},"reference":[{"key":"e_1_3_8_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1302674"},{"key":"e_1_3_8_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-004833"},{"key":"e_1_3_8_5_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2021.1985890"},{"key":"e_1_3_8_6_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0181565"},{"key":"e_1_3_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.04.013"},{"key":"e_1_3_8_8_1","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.027451"},{"key":"e_1_3_8_9_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2020.1847582"},{"key":"e_1_3_8_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-1898-z"},{"key":"e_1_3_8_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-024-00963-w"},{"key":"e_1_3_8_12_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2024.2344983"},{"key":"e_1_3_8_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.11.002"},{"key":"e_1_3_8_14_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-017-0420-9"},{"key":"e_1_3_8_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2017.10.009"},{"key":"e_1_3_8_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiac255"},{"key":"e_1_3_8_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz1090"},{"key":"e_1_3_8_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz769"},{"key":"e_1_3_8_19_1","unstructured":"Public Health Agency of Canada. Canadian immunization guide. [Internet]. [cited 2023 Oct 8]. Available from: https:\/\/www.canada.ca\/en\/public-health\/services\/canadian-immunization-guide.html"},{"key":"e_1_3_8_20_1","unstructured":"GSK Canada. Shingrix. Herpes Zoster vaccine (non-live recombinant AS01B adjuvanted). 2022. [Internet]. [cited 2023 Aug 9]. Available from: https:\/\/ca.gsk.com\/en-ca\/products\/shingrix"},{"key":"e_1_3_8_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k4029"},{"key":"e_1_3_8_22_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.190274"},{"key":"e_1_3_8_23_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1442162"},{"key":"e_1_3_8_24_1","unstructured":"National Advisory Committee on Immunization (NACI). National advisory committee on immunization update on the use of herpes zoster vaccines. Ottawa (ON): PHAC; 2018. [Internet]. [cited 2024 Nov 9]. Available from: https:\/\/www.canada.ca\/en\/services\/health\/publications\/healthy-living\/updated-recommendations-use-herpes-zoster-vaccines.html"},{"key":"e_1_3_8_25_1","doi-asserted-by":"publisher","DOI":"10.14745\/ccdr.v44i09a06"},{"key":"e_1_3_8_26_1","unstructured":"Comit\u00e9 sur l\u2019immunisation du Qu\u00e9bec (CIQ). Avis sur la pertinence d\u2019ajouter la vaccination contre le zona au programme qu\u00e9b\u00e9cois d\u2019immunisation. February 2018. [Internet]. [cited 2023 Aug 11]. Available from: https:\/\/www.inspq.qc.ca\/sites\/default\/files\/publications\/2381_pertinence_vaccination_zona_programme_quebecois_immunisation.pdf"},{"key":"e_1_3_8_27_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6703a5"},{"key":"e_1_3_8_28_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2021.1956906"},{"key":"e_1_3_8_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2022.10.063"},{"key":"e_1_3_8_30_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2023.2278362"},{"key":"e_1_3_8_31_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1501184"},{"key":"e_1_3_8_32_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1603800"},{"key":"e_1_3_8_33_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2019.1627818"},{"key":"e_1_3_8_34_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac485"},{"key":"e_1_3_8_35_1","unstructured":"A phase 3b Open-label multi-country multi-centre long-term follow-up study of ZOSTER-049 (follow-up of ZOSTER-006\/022 studies) to assess the prophylactic efficacy safety and persistence of immune response of a herpes zoster subunit vaccine and assessment of persistence of immune response and safety of 1 or 2 additional doses administered in ZOSTER-049 in 2 subgroups of older adult (NCT05371080). [Internet]. [cited 2024 Jun 13]. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT05371080"},{"key":"e_1_3_8_36_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2023.2263979"},{"key":"e_1_3_8_37_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.9053"},{"key":"e_1_3_8_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30163-X"},{"key":"e_1_3_8_39_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa424"},{"key":"e_1_3_8_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-021-01076-w"},{"key":"e_1_3_8_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.07.049"},{"key":"e_1_3_8_42_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7103a2"},{"key":"e_1_3_8_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.03.024"},{"key":"e_1_3_8_44_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24086967"},{"key":"e_1_3_8_45_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2023.2288282"},{"key":"e_1_3_8_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2016.12.620"},{"key":"e_1_3_8_47_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa005"},{"key":"e_1_3_8_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-023-02156-y"},{"key":"e_1_3_8_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/crj.13554"},{"key":"e_1_3_8_50_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-021-00535-7"},{"key":"e_1_3_8_51_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofae535"},{"key":"e_1_3_8_52_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2023-002130"},{"key":"e_1_3_8_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcjd.2017.10.060"},{"key":"e_1_3_8_54_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-2053"},{"key":"e_1_3_8_55_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000025292"},{"key":"e_1_3_8_56_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.39670"},{"key":"e_1_3_8_57_1","doi-asserted-by":"publisher","DOI":"10.1093\/gastro\/goad016"},{"key":"e_1_3_8_58_1","doi-asserted-by":"publisher","DOI":"10.2147\/PTT.S430151"},{"key":"e_1_3_8_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2017.12.052"},{"key":"e_1_3_8_60_1","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izy311"},{"key":"e_1_3_8_61_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.220986"},{"key":"e_1_3_8_62_1","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2021.1886924"},{"key":"e_1_3_8_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.12.073"},{"key":"e_1_3_8_64_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-023-00988-y"},{"key":"e_1_3_8_65_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofw205"},{"key":"e_1_3_8_66_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy625"},{"key":"e_1_3_8_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2021.05.029"},{"key":"e_1_3_8_68_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.01.001"},{"key":"e_1_3_8_69_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.17379"},{"key":"e_1_3_8_70_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-220822"},{"key":"e_1_3_8_71_1","doi-asserted-by":"publisher","DOI":"10.1080\/14397595.2020.1812201"},{"issue":"6","key":"e_1_3_8_72_1","first-page":"962","article-title":"Does methotrexate increase the risk of varicella or herpes zoster infection in patients with rheumatoid arthritis? A systematic literature review","volume":"30","author":"Zhang N","year":"2012","unstructured":"Zhang N, Wilkinson S, Riaz M, et al. Does methotrexate increase the risk of varicella or herpes zoster infection in patients with rheumatoid arthritis? A systematic literature review. Clin Exp Rheumatol. 2012;30(6):962\u2013971.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_8_73_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2011.04230.x"},{"key":"e_1_3_8_74_1","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izab092"},{"key":"e_1_3_8_75_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-220651"},{"key":"e_1_3_8_76_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.1099"},{"key":"e_1_3_8_77_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.665559"},{"key":"e_1_3_8_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.03.017"},{"key":"e_1_3_8_79_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2014.3065"},{"key":"e_1_3_8_80_1","unstructured":"Comit\u00e9 sur l\u2019immunisation du Qu\u00e9bec (CIQ). Vaccination des personnes immunosupprim\u00e9es \u00e2g\u00e9es de 18 \u00e0 49 ans et des adultes avec des maladies chroniques: vaccin sous-unitaire adjuvant\u00e9 contre le zona (zona-SU). 2020 Nov 11. [Internet]. [cited 2023 Aug 11]. Available from: https:\/\/www.inspq.qc.ca\/publications\/2705"},{"key":"e_1_3_8_81_1","doi-asserted-by":"publisher","DOI":"10.1093\/jcag\/gwab016"},{"key":"e_1_3_8_82_1","unstructured":"Centers for Disease Control and Prevention (CDC). Clinical considerations for use of recombinant zoster vaccine (RZV shingrix) in immunocompromised adults aged \u226519 years. Available at cited 2024 Nov 6]. Available from: https:\/\/www.cdc.gov\/shingles\/hcp\/vaccine-considerations\/immunocompromised-adults.html"},{"key":"e_1_3_8_83_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.25045"},{"key":"e_1_3_8_84_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.24.00032"},{"key":"e_1_3_8_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2022.100548"},{"key":"e_1_3_8_86_1","unstructured":"Centers for Disease Control and Prevention. Vaccines & immunizations: altered immunocompetence. [cited 2025 Jan 5]. https:\/\/www.cdc.gov\/vaccines\/hcp\/imz-best-practices\/altered-immunocompetence.html"},{"key":"e_1_3_8_87_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit816"},{"key":"e_1_3_8_88_1","doi-asserted-by":"publisher","DOI":"10.4065\/mcp.2010.0618"},{"key":"e_1_3_8_89_1","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2019.34.e1"},{"key":"e_1_3_8_90_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-024-01101-7"},{"key":"e_1_3_8_91_1","doi-asserted-by":"publisher","DOI":"10.1177\/1203475418811335"},{"key":"e_1_3_8_92_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.42261"},{"key":"e_1_3_8_93_1","doi-asserted-by":"publisher","DOI":"10.1177\/1715163519877898"},{"key":"e_1_3_8_94_1","doi-asserted-by":"publisher","DOI":"10.1177\/1715163519879179"},{"key":"e_1_3_8_95_1","unstructured":"Canadian Pharmacists Association. Injection authority and vaccine administration in pharmacies across Canada. 2023 Aug. [Internet]. [cited 2024 Jun 14]. Available from: https:\/\/www.pharmacists.ca\/advocacy\/scope-of-practice\/"},{"key":"e_1_3_8_96_1","doi-asserted-by":"publisher","DOI":"10.1177\/17151635221128223"},{"key":"e_1_3_8_97_1","doi-asserted-by":"publisher","DOI":"10.1177\/1715163517710959"},{"key":"e_1_3_8_98_1","unstructured":"Immunize BC. Where can I get the shingles vaccine? How much does it cost? [Internet]. [cited 2025 Mar 1]. Available from: https:\/\/immunizebc.ca\/ask-us\/questions\/where-can-i-get-shingrix%E2%93%A1-vaccine"},{"key":"e_1_3_8_99_1","unstructured":"Gouvernement du Qu\u00e9bec. Vaccin contre le zona. Shingles vaccination program]. [Internet]. [cited 2023 Aug 29]. Available from: https:\/\/www.quebec.ca\/en\/health\/advice-and-prevention\/vaccination\/shingles-vaccination-program"},{"key":"e_1_3_8_100_1","unstructured":"Ontario Ministry of Health. Ontario publicly funded shingles (herpes zoster) immunization program: Shingrix\u00ae vaccine. Information for patients. [Internet]. 2022 Aug [cited 2023 Dec 16]. Available from: https:\/\/www.health.gov.on.ca\/en\/public\/programs\/immunization\/docs\/shingles_patient_fact_sheet_en.pdf"},{"key":"e_1_3_8_101_1","unstructured":"Yukon Ministry of Health and Social Services. Sept. Government of Yukon announces funding for shingles vaccine. [Internet]. 2020 [cited 2023 Dec 16]. Available from: https:\/\/yukon.ca\/en\/news\/government-yukon-announces-funding-shingles-vaccine"},{"key":"e_1_3_8_102_1","unstructured":"First Nations Health Authority. First Nations health authority expanding elders coverage of shingrix\u00ae shingles vaccine. [Internet]. 2021 Jan 29 [cited 2023 Dec 16]. Available from: https:\/\/www.fnha.ca\/benefits\/health-benefits-news\/first-nations-health-authority-expanding-elders-coverage-of-shingrix-shingles-vaccine"},{"key":"e_1_3_8_103_1","unstructured":"Prince Edward Island News. [Internet]. [cited 2023 Dec 16]. Available from: https:\/\/www.princeedwardisland.ca\/en\/news\/free-shingles-vaccine-for-island-seniors-in-january-2022"},{"key":"e_1_3_8_104_1","unstructured":"Public Health Agency of Canada. Provincial and territorial routine vaccination programs for healthy Previously immunized adults. [Internet]. [cited 2023 Oct 2]. Available from: https:\/\/www.canada.ca\/en\/public-health\/services\/provincial-territorial-immunization-information\/routine-vaccination-healthy-previously-immunized-adult.html"},{"key":"e_1_3_8_105_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2024.2317595"},{"key":"e_1_3_8_106_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0220230"},{"key":"e_1_3_8_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2020.09.010"},{"key":"e_1_3_8_108_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2022.04.018"},{"key":"e_1_3_8_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2022.12.016"},{"key":"e_1_3_8_110_1","unstructured":"Public Health Agency of Canada. An advisory committee statement (Acs)national advisory committee on immunization (NACI). Updated recommendations on herpes zoster vaccination for adults who are immunocompromised. May 2025. [Internet]. [cited 2025 Jun 11]. Available from: https:\/\/www.canada.ca\/content\/dam\/phac-aspc\/documents\/services\/publications\/vaccines-immunization\/national-advisory-committee-immunization-statement-guidance-covid-19-vaccines-2025-summer-2026\/naci-statement-2025-01-10.pdf"},{"key":"e_1_3_8_111_1","unstructured":"Public Health Agency of Canada. Summary of NACI statement of May 14 2025: updated recommendations on herpes zoster vaccination for adults who are immunocompromised. [Internet]. [cited 2025 May 28]. Available from: https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/vaccines-immunization\/national-advisory-committee-immunization-summary-updated-recommendations-herpes-zoster-vaccination-adults-immunocompromised.html"}],"container-title":["Expert Review of Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14760584.2025.2539884","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T06:43:47Z","timestamp":1765521827000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14760584.2025.2539884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,5]]},"references-count":109,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12,31]]}},"alternative-id":["10.1080\/14760584.2025.2539884"],"URL":"https:\/\/doi.org\/10.1080\/14760584.2025.2539884","relation":{},"ISSN":["1476-0584","1744-8395"],"issn-type":[{"type":"print","value":"1476-0584"},{"type":"electronic","value":"1744-8395"}],"subject":[],"published":{"date-parts":[[2025,8,5]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-09-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}